Before celebrating supposed Alzheimer's treatment, a word of caution
A medical professional warns against prematurely celebrating unproven treatments for complex diseases like Alzheimer's, citing the historical failure of the Zamboni treatment for multiple sclerosis. The piece emphasizes the importance of rigorous clinical trials over anecdotal evidence.
Why it matters
It highlights the dangers of medical misinformation and the necessity of evidence-based medicine in patient care.
Every once in a while, some oddball treatment for difficult to treat diseases emerges. In my career, one example was the Zamboni treatment for multiple sclerosis, which took the MS world of patients, caregivers and some governments by storm, especially in Canada in 2009.
Paolo Zamboni was an Italian vascular surgeon who proposed the radical idea that MS was caused by obstructions of draining views from the brain and spinal cord, for which he proposed opening the veins by balloon catheters inserted into the affected veins and then inflating them.
His evidence was based on before-and-after graphic venograms illustrating blocked veins, opened up by surgery and patient claims that they were much better following the treatment — evidence which was compellingly impressive to patients, their families and some physicians.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in